Vaccination

FDA questions strength of Johnson & Johnson's booster shot data

In a development that could mean Johnson & Johnson might encounter resistance over its application for authorization of a booster shot of its coronavirus vaccine, a new analysis filed by the U.S. Food and Drug Administration ...

Medications

Potential new drug combination for some skin cancers

A combination of two existing skin cancer drugs and a third experimental drug could lead to a new strategy for treating patients who do not respond to existing therapies, a new study in mice suggests.

Oncology & Cancer

Deploying an ancient defense to kill cancer

A recent small trial in 15 cancer patients with advanced soft-tissue sarcomas aimed to find out whether an experimental drug based on a certain bacterial molecule could trigger an immune response to fight cancer.

page 32 from 40